fashion -WSS

fashion

author：comprehensive 2025-08-29 01:53:37 - browse：72

A nurse prepares to administer chemotherapy treatment. -- Cancer coverage from STAT — Preparing a chemotherapy treatment at Duke Cancer Center in Durham, N.C. Gerry Broome/AP

A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic with acute lymphoblastic leukemia, the most common of all childhood cancers. One of the drugs needed for treatment was methotrexate. The only problem was that the drug was in short supply.

“Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkins School of Medicine. “It’s just so, so maddening.”

Methotrexate isn’t the only essential chemotherapy clinicians are having a hard time getting their hands on right now. Two other key chemotherapies, cisplatin and carboplatin, which are also generic injectable drugs, have been in shortage for the last few months. But Unguru didn’t see this particular patient recently or even in the last year. He saw her over a decade ago, when the country was facing a different methotrexate shortage back in 2012.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Neuroscience startup Neumora files for IPO

focus

WSS

NYU Langone launches private ChatGPT for its health care data

Medical device lobby: We're tired of waiting on Medicare coverage

Diversity in medical illustrations gets boost from Chidiebere Ibe

How to make Best Hospitals ratings actually useful for patients

Covid isolation guidance eased by the CDC

Appeals court upholds limits to abortion pill

focus

fashion

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

AstraZeneca challenges Medicare drug negotiation program

After affirmative action ruling, medical educators look to 'holistic review'

As pharma fights Medicare drug negotiation, hospitals, docs silent

As demand for Covid shots wanes, Moderna seeks its next success

Feds fine Medicare Advantage plans for overcharging members

Psychedelics group wrestles with new pharma identity

AstraZeneca challenges Medicare drug negotiation program

Medical leaders decry Supreme Court decision on affirmative action

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

hotspot

ALS groups 'won't be played again' by the FDA, drug sponsors

Apellis safety probe of eye disease drug centers on injection needle

Kenai launches with $82 million for Parkinson’s stem cell therapy

As pharma fights Medicare drug negotiation, hospitals, docs silent

FogPharma raises $145 million in rare Series E round

International team creates first chimeric human

Wikipedia

focus

focus

hotspot